Fulminant Hepatic Failure
📧 Sign up to get email alerts when something new happens for Fulminant Hepatic Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Maternal And Fetal Outcomes in Pregnant Women With Liver Disease
A completed clinical trial evaluating maternal and fetal outcomes in pregnant women with fulminant hepatic failure.
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Steroids in Fulminant Hepatitis A in the Pediatric Age Group [Phase 4]
A Phase 4 clinical trial evaluating steroids for fulminant hepatic failure in pediatric patients has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF) [Phase 2]
Phase 2 trial evaluating the ELAD System for acute liver failure was terminated; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2015-10-27Clinical Trial Update: Cerebral Microdialysis in Patients With Fulminant Hepatic Failure
This clinical trial update notes the completion of a study evaluating cerebral microdialysis in patients with fulminant hepatic failure cond…
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: Study of N-Acetylcysteine in Acute Liver Failure (ALF) [Phase 4]
Phase 4 trial of N-Acetylcysteine in acute liver failure was terminated with results posted in 2014.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure [Phase 2]
Phase 2 evaluation of the ELAD System for acute liver failure has been completed. The update notes sponsor Vital Therapies, Inc. and the cur…
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic Failure [Phase 3]
Phase 3 trial evaluating the MARS Albumin Dialysis System in patients with fulminant and subfulminant hepatic failure has completed.